Page last updated: 2024-08-26

2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine and Carcinoma, Hepatocellular

2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine has been researched along with Carcinoma, Hepatocellular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabibbo, A; Ciapponi, L; Ciliberto, G; Klein, B; Lahm, A; Paonessa, G; Pulkki, K; Savino, R; Sporeno, E; Sun, RX; Toniatti, C1

Other Studies

1 other study(ies) available for 2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine and Carcinoma, Hepatocellular

ArticleYear
Human interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells.
    Blood, 1996, Jun-01, Volume: 87, Issue:11

    Topics: Antigens, CD; Carcinoma, Hepatocellular; Growth Inhibitors; Humans; Interleukin-6; Liver Neoplasms; Melanoma; Models, Molecular; Morpholines; Multiple Myeloma; Neoplasm Proteins; Peptide Fragments; Polymerase Chain Reaction; Protein Conformation; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Structure-Activity Relationship; Tumor Cells, Cultured

1996